Controlled Substances and Substance Abuse: Best Practices for the Healthcare Professional - 2 AOA Category 1-A Credits

Tracking # 20-1350021

$150.00

There are no ratings for this course

Educator ACHIEVE CE - EDUCATION SERVICES

CE Broker Reporting Reported automatically

Method Computer-Based Training

What you'll learn

Provided by an AOA-accredited Category 1 CME sponsor, this activity is eligible for AOA Category 1-A credit and includes instructor interaction; questions submitted by email will receive a response within 48 hours. Prescribing controlled substances remains one of the highest-risk areas of clinical practice, with real consequences for patient safety, regulatory compliance, and professional liability. This course provides osteopathic physicians with a practical, clinically focused review of federally regulated controlled substances, including stimulants, opioids, sedatives, and tranquilizers, so you can prescribe with greater confidence and consistency.

Participants will strengthen their ability to recognize misuse risk, apply safer prescribing strategies, and identify early warning signs of diversion or substance use disorder. The activity also emphasizes documentation and decision-making practices that support appropriate therapeutic use while reducing preventable harm. Designed for real-world patient encounters, this training equips clinicians to balance symptom relief with risk reduction, protect patients, and support responsible controlled substance management in everyday care.

Course overview

Provided by an AOA-accredited Category 1 CME sponsor, this activity is eligible for AOA Category 1-A credit and includes instructor interaction; questions submitted by email will receive a response within 48 hours. This activity is organized around the decisions prescribers actually make when using controlled substances such as opioids, stimulants, sedatives, and tranquilizers, balancing meaningful symptom relief against the risks of misuse, diversion, overdose, and substance use disorder. It addresses whether to initiate a controlled substance, how to monitor and reassess therapy, when to mitigate risk and offer naloxone, how to manage pain in special populations such as patients with sickle cell disease, and when to taper, refer, or evaluate for a substance use disorder. The content reflects current, guideline-based practice consistent with the CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022) and other contemporary standards and applies to both physicians and physician assistants who prescribe controlled substances.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Medical Board - Medical Doctors & Osteopathic Doctors